San Diego – June 13, 2016 – Cooley advised the underwriters on NantHealth's $96.6 million initial public offering. The company now trades on the NASDAQ Global Select Market under the symbol "NH."
Jefferies and Cowen and Company acted as joint book-running managers for the offering and First Analysis Securities Corporation, Canaccord Genuity and FBR Capital Markets & Co acted as co-managers.
NantHealth is a next generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses.
The Cooley corporate and securities team included Charlie Kim, Sean Clayton, David Peinsipp, Drew Williamson, Kristin VanderPas, Carlos Ramirez, Adrienne Directo, Katy Pine, Susan Walker and Edmond Lay.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.